冠状动脉微血管功能障碍和高血压:一种比我们想象的更重要的纽带
Marija Zdravkovic1,2, Viseslav Popadic1, Slobodan Klasnja1
1Clinic for Internal Medicine, University Clinical Hospital Center Bezanijska Kosa, 11000 Belgrade, Serbia.
Medicina (Kaunas, Lithuania)
|December 23, 2023
概括
冠状动脉微血管功能障碍 (CMD) 在高血压中导致心脏损伤和心痛. 早期诊断和治疗对于管理这种情况和预防心力衰竭至关重要.
科学领域:
- 心脏病学 心脏病学
- 高血压研究 高血压研究
- 血管生物学 血管生物学
背景情况:
- 冠状动脉微血管功能障碍 (CMD) 是心脏病发病率和死亡率的重要因素,通常与高血压有关.
- 高血压诱导功能和结构微血管变化,通过内皮功能障碍和毛细血管稀疏导致微血管性心痛.
- 慢性心脏病与心肌变化有关,如左心室缩和腹功能障碍,作为心力衰竭的标志物,具有保存的射出分数.
研究的目的:
- 审查高血压患者中CMD的病理生理机制.
- 为CMD提供综合诊断方法.
- 为CMD提供当前治疗策略的概述.
主要方法:
- 综合文献综述,重点关注高血压患者的CMD病理生理学,诊断和治疗.
- 对诊断方式的分析,包括非侵入性和侵入性技术.
- 评估治疗选择及其对预后的影响.
主要成果:
- 高血压通过内皮功能障碍和毛细血管稀疏显著导致CMD.
- 冠状动脉疾病是末端器官损伤和心力衰竭的早期指标,特别是在高血压患者中.
- 有许多诊断工具来评估CMD的严重程度和指导治疗.
结论:
- 高血压患者的CMD是一个关键的临床实体,需要彻底调查.
- 对于高血压患者,胸痛和没有阻塞性冠状动脉疾病的患者,对微血管性心痛的查是必不可少的.
- 综合诊断和治疗方法对于管理CMD和改善患者结果至关重要.
相关概念视频
Hypertension and Regulation of Blood Pressure
2.1K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.1K
Disorders of the Autonomic Nervous System
653
The autonomic nervous system (ANS) is an intricate network of nerves that controls functions such as the regulation of heart rate, digestion, and blood pressure regulation. When this system malfunctions, it can lead to various disorders that affect multiple bodily functions. One common feature of many autonomic disorders is the involvement of smooth blood vessels, which play a crucial role in regulating blood flow throughout the body.
Raynaud's disease, also known as Raynaud's...
Raynaud's disease, also known as Raynaud's...
653
Factors affecting Blood pressure
3.2K
Several physiological and lifestyle factors influence blood pressure (BP). Understanding these factors is crucial as they are significant in patient education and blood pressure management.
Physiological Factors:
Physiological Factors:
3.2K
Hormonal Regulation of Blood Pressure
2.6K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.6K
Pulmonary Hypertension: Classification and Pathogenesis
188
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
188
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436


